Irbediur

Irbesartan, the active ingredient in Irbediur, is an Angiotensin II receptor blocker (ARB) combined with a thiazide diuretic, presented as a tablet for oral use. It treats hypertension, often in adults who require additional blood‑pressure control beyond monotherapy.

GNH USA supplies Irbediur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbediur is used to manage conditions within the cardiovascular and renal disease spectrum where blood‑pressure reduction is required. - Hypertension: lowers systolic and diastolic pressure, helping to prevent stroke and heart attack. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes. - Left ventricular hypertrophy: reduces cardiac workload by controlling elevated blood pressure.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: general tiredness or lack of energy. - Increased urination: more frequent need to void. - Electrolyte imbalance: changes in potassium or sodium levels. - Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Hyperkalemia: dangerously high potassium that can affect heart rhythm. - Acute kidney injury: sudden decline in renal function. - Angioedema: swelling of face, lips, tongue, or throat. - Severe allergic reaction: rash, itching, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, consider the following precautions. - Blood pressure monitoring: ensure target levels are achieved without excessive drop. - Electrolyte assessment: regularly check potassium and sodium concentrations. - Renal function evaluation: assess creatinine and eGFR, especially in patients with pre‑existing kidney disease. - Pregnancy avoidance: drug is contraindicated in pregnancy due to fetal risk. - NSAID use: avoid concurrent non‑steroidal anti‑inflammatory drugs that may impair renal function. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Irbediur may interact with several medicines; awareness of these interactions helps maintain safety. Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Lithium: increased lithium levels leading to toxicity. - ACE inhibitors or other ARBs: additive effects on blood pressure and renal function. Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive efficacy and affect kidney function. - Antidiabetic agents: potential for enhanced hypoglycaemia. - CYP2C9 inhibitors (e.g., fluconazole): may raise irbesartan concentrations.